RICOVR highlights benefits of point-of-care drug testing in global scientific peer-reviewed journal collaboration

SHARE THIS POST:

Share on facebook
Share on twitter
Share on linkedin
Share on email


Point-of-care drug testing devices can accurately detect drugs-of-abuse and increase safety within communities & workplaces.

PRINCETON, NJ, US, January 24, 2022 /EINPresswire.com/ — RICOVR Healthcare announces a scientific publication on emerging point-of-care devices for drug testing. The article, “Emerging trends in point-of-care sensors for illicit drugs analysis,” was published in the prestigious peer-reviewed Talanta journal and was authored by Dr. Himanshu Bhatia, Founder and CEO of RICOVR Healthcare along with Manisha Dagara, Sangeeta Yadav, V.V.R. Sai, & Jitendra Satijac.

According to the article, “Consumption of illicit narcotic drugs and fatal or criminal activities under their influence has become an utmost concern worldwide. These drugs influence an individual’s feelings, perceptions, and emotions by altering the state of consciousness and thus can result in serious safety breaches at critical workplaces.”

With the help of the rapid point-of-care testing, one can use immensely sensitive nanosensor technology that was once only available in labs.”

— Dr. Himanshu Bhatia, Founder and CEO, RICOVR Healthcare

To overcome these problems, point-of-care drug-testing devices have become very important in recent times. Law enforcement agencies and employers use these testing devices to increase safety and lower risk.

Progress has been made on the different electrochemical and optical nanosensors. They have been designed and developed solely to analyze illicit drugs like cocaine (COC), benzodiazepine (BZDs), tetrahydrocannabinol (THC), opioids (OPs), amphetamines & methamphetamine.

“With the help of the rapid point-of-care testing, one can use immensely sensitive nanosensor technology that was once only available in labs. It will make great changes in detecting illicit drug use at workplaces, roadside, and other places,” said Dr. Himanshu Bhatia, Founder and CEO, RICOVR Healthcare.

These electrochemical and optical nanosensors come with multiple sensing modalities and evolving parameters like real-time monitoring or measuring with the help of a smart user interface. It is a versatile technique and aids in understanding the pharmacodynamic and pharmacokinetic effects from the use of illicit drugs.

The full journal article can be accessed by clicking here.

Our LATEST STORIES